XTL Biopharmaceuticals Ltd. elected Mrs. Iris Shapira Yalon to hold office as external director of the Company Board of Directors, commencing as of the Meeting date and for a period of 3 years thereon and also Doron Turgeman as Chief Executive Officer of the Company, including his terms of employment in such capacity, at its annual general meeting held on January 29, 2020.
XTL Biopharmaceuticals Ltd. TEL AVIV STOCK EXCHANGE
Equities
XTLB
IL0010854979
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+23.62% | 47.96B | |
+0.20% | 42.45B | |
+43.96% | 41.47B | |
+25.87% | 31.6B | |
+19.48% | 28.63B | |
-4.47% | 28.03B | |
+51.39% | 14.56B | |
+44.08% | 14.14B | |
+1.94% | 12.58B |